Skip to Content
You are currently on the new version of our website. Access the old version .

Antibodies, Volume 15, Issue 4

2026 August - 26 articles

Cover Story: The interaction between human immunoglobulin G (IgG)1 Fc and the Fc gamma receptor (FcγR) IIIa/CD16a elicits protective immune responses. Antibody N-glycosylation stabilizes the FcγR-binding interface and is thus essential for interaction with wildtype IgG1 Fc. Furthermore, the N-glycan introduces substantial compositional and functional heterogeneity, with distinct glycoforms providing different affinities and discrete responses in vivo. Accordingly, various engineering endeavors to improve antibody binding strive to boost the therapeutic efficacy of monoclonal antibodies but do not directly address compositional heterogeneity. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (26)

  • Article
  • Open Access
1,062 Views
19 Pages

12 August 2026

GNR-068 is a proposed biosimilar to the ustekinumab reference product (RP), which works through the antagonism of interleukin 12 and interleukin 23. Ustekinumab RP is used for the treatment of chronic inflammatory conditions, including certain forms...

(This article belongs to the Special Issue Immune Phenomena in Autoimmune Skin Disorders)
  • Article
  • Open Access
995 Views
18 Pages

A CSF-1R Ig4-5 Domain-Targeting Antibody for the Treatment of Idiopathic Pulmonary Fibrosis

  • Wusong Luo,
  • Zhe Shao,
  • Tao Wang,
  • Kenghoe Lok and ,
  • Rongjing Zhang and
  • Yao Li
  • + 1 author+ 0 author

11 August 2026

Background: Idiopathic pulmonary fibrosis (IPF) is closely associated with fibroblast proliferation, macrophage polarization, and the accumulation of extracellular matrix (ECM). Targeting CSF-1R can rebalance macrophages, reduce ECM deposition, and b...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
1,498 Views
21 Pages

Advances in the Development of a Universal Influenza Vaccine

  • Preanka Mudaly,
  • Max Lee,
  • Aishwarya Bhatta and
  • Craig Thompson

11 August 2026

Influenza remains a persistent global health threat, accounting for an estimated one billion infections and 350,000–600,000 deaths worldwide annually. Beyond substantial mortality and morbidity, influenza imposes major socio-economic costs thro...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
673 Views
13 Pages

11 August 2026

Background: Ocular myasthenia gravis (OMG) can remain restricted to ocular symptoms or progress to generalized myasthenia gravis (GMG). However, the rate of generalization and its predictors may vary across populations, and data on South Korean patie...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
922 Views
12 Pages

Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series

  • Orsola Crespi,
  • Umberto Santaniello,
  • Luca Cangialosi,
  • Ambra Bonvicino and ,
  • Michela Ortoncelli,
  • Francois Rosset,
  • Luca Mastorino,
  • Simone Ribero and
  • Pietro Quaglino
  • + 4 authors+ 0 author

11 August 2026

Background/Objectives: Congenital ichthyoses (CI) are inherited disorders of keratinization characterized by epidermal barrier dysfunction, abnormal desquamation, and variable degrees of inflammation. Increasing evidence suggests a role for IL-23/Th1...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
915 Views
13 Pages

7 August 2026

Background: Sex-related differences in SARS-CoV-2 viral susceptibility, severity, and recovery are prevalent. Factors such as age and biological variation provide some explanation for immune response, yet the use of biological sex as a variable may l...

(This article belongs to the Special Issue Antiviral Antibody Immune Responses in the Context of Vaccination and Infection)
  • Review
  • Open Access
1,335 Views
9 Pages

6 August 2026

Inflammatory bowel diseases (IBDs), chronic inflammatory disorders of the gastrointestinal tract, are classified into Crohn’s disease (CD) and ulcerative colitis (UC). Despite differing clinical manifestations, both CD and UC share a common imm...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
1,486 Views
18 Pages

6 August 2026

Sickle cell disease (SCD) represents one of the most complex hematological diseases leading to a lifetime of physiological crises characterized by chronic hemolysis, inflammation, hypoxia, and anemia with changes to body systems that result in patien...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,143 Views
19 Pages

Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation

  • Antonella Bruzzese,
  • Enrica Antonia Martino,
  • Santino Caserta,
  • Maria Eugenia Alvaro and ,
  • Nicola Amodio,
  • Eugenio Lucia,
  • Virginia Olivito,
  • Caterina Labanca,
  • Francesco Mendicino and
  • Massimo Gentile
  • + 7 authors+ 2 authors

4 August 2026

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts and the persistence of leukemic stem cells (LSCs) within a profoundly remodeled bone marrow (BM) microenvironment. Despite...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
667 Views
21 Pages

4 August 2026

Background/Objectives: Aryl hydrocarbon receptor (AHR) ligands are known to suppress antibody production. However, it remains unclear whether this suppression translates into altered antibody-mediated Fcγ receptor signaling in human cells. This...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,610 Views
24 Pages

Functional Parameters of Hybridoma Cells: Methods of Evaluation and Biotechnological Relevance

  • Tatiana Bezukladnikova,
  • Svetlana Zamorina,
  • Sergey Lazarev and
  • Mikhail Rayev

4 August 2026

Hybridoma technology remains one of the most reliable and widely used platforms for generating highly specific monoclonal antibodies for use in diagnostics, fundamental research, and clinical practice. Moreover, the combination of unlimited prolifera...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
4,196 Views
14 Pages

Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity

  • Felix Meiser,
  • Julia Harwardt,
  • Christoph Hahn,
  • Marta Lustig and ,
  • Thomas Valerius and
  • Harald Kolmar
  • + 1 author+ 0 author

Background/Objectives: CD89 (FcaRI), the receptor for immunoglobulin A (IgA), is expressed on myeloid cells, including neutrophils, monocytes, and macrophages. It is known to mediate potent effector functions against tumor cells, but the clinical dev...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
953 Views
18 Pages

Biopsy-Confirmed Acute Interstitial Nephritis in Patients Treated with Immune Checkpoint Inhibitors: A Single-Center Retrospective Case Series

  • Ioannis Ogrotis,
  • Konstantinos Drouzas,
  • Evangelia Pantzopoulou,
  • Petros Nikolopoulos and ,
  • Ioannis Kotsantis,
  • Amanda Psyrri,
  • George Liapis and
  • Sophia Lionaki
  • + 3 authors+ 0 author

Background/Objectives: Acute interstitial nephritis (AIN) is a cause of acute kidney injury (AKI) during immune checkpoint inhibitor (ICI) therapy, but biopsy-confirmed data are limited. We estimated institutional proportions of biopsy-confirmed AIN...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
777 Views
13 Pages

Background: The elicitation of broadly neutralizing antibodies against conserved antigenic epitopes has been a focus of universal vaccine research. To facilitate immunofocusing on the conserved influenza hemagglutinin (HA) stalk, we designed headless...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
2,457 Views
27 Pages

Although mAbs have great therapeutic potential, their use in medicine is currently limited by the high cost of their manufacturing. Significant developments in upstream processing technologies have caused downstream processing (DSP) to become the man...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
593 Views
14 Pages

Sera of Healthy First-Degree Relatives of SLE Patients Contain Autoantibodies to Globular Domains of C1q

  • Ginka Cholakova,
  • Alexandra Atanasova,
  • Alexandra Kapogianni,
  • Dobroslav Kyurkchiev and ,
  • Bogdan Penev and
  • Ivanka Tsacheva
  • + 1 author+ 0 author

Background/Objectives: The autoimmune disorder Systemic Lupus Erythematosus (SLE) is characterized by increased titers of autoantibodies with different specificities against autoantigens, including the complement proteins C1q, C3 and Factor H. SLE is...

(This article belongs to the Special Issue Antibody and Autoantibody Specificities in Autoimmunity)
  • Review
  • Open Access
1,384 Views
22 Pages

Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention

  • Bogdan Ghilencea,
  • Bianca Ilinca Moroianu,
  • Ancuța-Iuliana Năstac,
  • Ioana-Stefania Bostan and ,
  • Anca Panaitescu,
  • Claudia Mehedințu and
  • Nicolae Gică
  • + 2 authors+ 0 author

Human Papillomavirus (HPV) infection is the leading cause of cervical cancer, presenting a significant global health challenge. While natural infection is widespread, the resulting immune response is often characterized by weak, delayed, and type-spe...

(This article belongs to the Section Humoral Immunity)
  • Review
  • Open Access
1,565 Views
13 Pages

The Diagnostic and Clinical Significance of Anti-Mutated Citrullinated Vimentin Antibodies in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Scoping Review

  • Christian D’Elia,
  • Giada Santagata,
  • Serena Guiducci,
  • Holger Bang and ,
  • Mariangela Manfredi,
  • Maria Infantino and
  • Maurizio Benucci
  • + 2 authors+ 0 author

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is one of the most severe extra-articular manifestations of rheumatoid arthritis (RA), requiring reliable biomarkers for early detection. This scoping review synthesized current evide...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
1 Citations
1,478 Views
20 Pages

A Novel Anti-Cadherin-17 Monoclonal Antibody, Ca17Mab-5, for Multiple Applications

  • Reina Ito,
  • Hiroyuki Suzuki,
  • Kenichiro Ishikawa,
  • Kazutake Yagi and ,
  • Akira Ohkoshi,
  • Yukio Katori,
  • Mika K. Kaneko and
  • Yukinari Kato
  • + 3 authors+ 0 author

Background/Objectives: Cadherin-17 (CDH17, LI-cadherin) is a non-classical cadherin with an atypical structure and unique functions. CDH17 expression is restricted to normal intestinal epithelium. Furthermore, CDH17 functions as an oncoprotein that p...

(This article belongs to the Special Issue Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization)
  • Article
  • Open Access
1,166 Views
13 Pages

Background: Antinuclear antibodies (ANA) can be detected in patients with rheumatoid arthritis (RA) and pose many diagnostic challenges, especially when RA presents an atypical course and requires differentiation from other systemic connective tissue...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Review
  • Open Access
2 Citations
1,254 Views
13 Pages

Daratumumab, a human IgG1 monoclonal antibody targeting CD38, is widely used in multiple myeloma and AL amyloidosis. Despite its clinical success, many patients fail to achieve durable responses or relapse, underscoring the importance of understandin...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Article
  • Open Access
1,245 Views
13 Pages

Phage-Selected Clickable Gln-Donor Peptide for Lys-Selective Fab Labeling Using Engineered Microbial Transglutaminase

  • Eva Agustriana,
  • Koki Murozono,
  • Kosuke Minamihata,
  • Riko Nishioka and
  • Noriho Kamiya

Background/Objectives: The use of cross-linking enzymes for site-selective and efficient antibody modification has attracted considerable attention. Microbial transglutaminase (MTG)-mediated labeling of IgG at Gln295 has emerged as a promising strate...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
1,891 Views
17 Pages

Immune-mediated neutropenias comprise a heterogeneous group of disorders characterized by antibody-mediated destruction of neutrophils, in which the detection of anti-neutrophil antibodies remains a significant diagnostic challenge. Human neutrophil...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
1,647 Views
12 Pages

Background: The interaction between human immunoglobulin G (IgG)1 Fc and the Fc gamma receptor (FcγR) IIIa/CD16a elicits protective immune responses. Antibody N-glycosylation stabilizes the FcγR-binding interface and is thus essential for...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
1,395 Views
17 Pages

pIgR Stem Zone-Targeted Nanobodies as Apical-to-Basolateral Carriers for Inhaled Biologic Delivery Across Mucosal Barriers

  • Aidong Qiu,
  • Ruiyuan Wang,
  • Yangyingjie Bai,
  • Bowen Zhang and ,
  • Xinyu He,
  • Jiani Xie and
  • Jianghai Liu
  • + 2 authors+ 0 author

Background: The mucosal barrier presents a significant challenge for non-invasive delivery of macromolecular therapeutics, often requiring administration with poor bioavailability and increased toxicity risks. The polymeric immunoglobulin receptor (p...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
1,276 Views
14 Pages

Background: Viral attachment mediated by host cell surface receptors is the first step in viral infection. As a key cell surface receptor, heparan sulfate (HS) mediates the attachment and entry of numerous non-enveloped viruses in livestock, thereby...

(This article belongs to the Section Antibody Discovery and Engineering)
XFacebookLinkedIn
Antibodies - ISSN 2073-4468